myHealthHub for Older Adult Inpatients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05450445 |
Recruitment Status :
Not yet recruiting
First Posted : July 8, 2022
Last Update Posted : July 8, 2022
|
Sponsor:
Lady Davis Institute
Information provided by (Responsible Party):
Soham Rej MD, MSc, Lady Davis Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
This study will assess "myHealthhub" in hospitalized older adults throughout 5 days of their hospital stay. The investigators propose a mixed method randomized controlled trial (RCT) comparing myHealthHub platform vs. a simplified HealthHub system that provides only TV access, in order to evaluate patients' loneliness, stress, quality of life, patient engagement, and other mental health outcomes in n=60 older adult inpatients. The investigators will also use qualitative methods to assess user and stakeholder experience, and engagement.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Patient Engagement Stress Loneliness Quality of Life | Device: myHealthHub Device: TV-only | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Outcomes Assessor) |
Primary Purpose: | Supportive Care |
Official Title: | myHealthHub for Older Adult Inpatients to Lower Loneliness and Improve Patient Engagement, Quality of Life and Mental Health |
Estimated Study Start Date : | September 1, 2022 |
Estimated Primary Completion Date : | September 1, 2023 |
Estimated Study Completion Date : | September 1, 2023 |
Arm | Intervention/treatment |
---|---|
Experimental: Intervention: myHealthHub |
Device: myHealthHub
myHealthHub is a multimodal patient engagement platform delivered on bedside terminals to provide hospital inpatients with social connection, meal ordering services, entertainment (TV, etc.), and access to medical care team. |
Active Comparator: Active control: TV-only |
Device: TV-only
myHealthHub device equipped with the TV-only entertainment option. |
Primary Outcome Measures :
- Changes in Loneliness [ Time Frame: Baseline, day 2, day 3, day 4, day 5 ]Loneliness measured by the UCLA 3-item Loneliness Scale (UCLA-3). This is a 3-item scale with scores ranging from 3-9, with higher scores indicating greater severity of loneliness.
Secondary Outcome Measures :
- Changes in Stress [ Time Frame: Baseline, day 3, day 5 ]Stress measured by Perceived Stress Scale (PSS). This is a 14-item scale with scores ranging from 0-56, with higher scores indicating greater severity of stress.
- Changes in Patient Engagement [ Time Frame: Baseline, day 3, day 5 ]Patient engagement measured by Patient Activation Measure-13 (PAM-13). This is a 13-question scale.
- Changes in Quality of Life in Older Adults [ Time Frame: Baseline, day 3, day 5 ]Quality of life which will be measured by the Euro-Quality of Life (EQ-5D). This is a 5-component scale including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
Other Outcome Measures:
- Feasibility Outcome: Enrollment [ Time Frame: Day 5 ]Enrollment rate (percent of participants enrolled from eligible participants)
- Feasibility Outcome: Recruitment [ Time Frame: Day 5 ]Recruitment target (ability to recruit 60 participants)
- Feasibility Outcome: Retention [ Time Frame: Day 5 ]Retention rate (percent of randomized participants who complete 5-day assessments in both arms)
- Exploratory Outcome: Changes in Depression [ Time Frame: Baseline, day 5 ]Depression measured by the Patient Health Questionnaire-9 (PHQ-9). This is a 9-question scale with scores ranging from 0-27, with higher scores indicating greater severity of depression.
- Exploratory Outcome: Changes in Anxiety [ Time Frame: Baseline, day 5 ]Anxiety measured by Generalized Anxiety Disorder-7 (GAD-7) scale. This is a 7-question scale with scores ranging from 0-21, with higher scores indicating greater severity of anxiety.
- Qualitative Component: Semi-structured interviews [ Time Frame: Day 5 ]The qualitative outcome of this RCT will analyze the experiences, barriers, and engagement of older adults with the myHealthHub device. It will also explore the experiences and limitations of hospital support staff with myHealthHub service.
Information from the National Library of Medicine
![](/ct2/html/images/NIH_NLM_ABRV_BLK_4.png)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 60 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Criteria
Quantitative Component:
Inclusion Criteria:
- ≥60 years old
- Admitted to non-surgical hospital unit
- Speak English or French
- Capable of giving consent
Exclusion Criteria:
- Delirium
- Active suicidal ideation
- Moderate/severe dementia diagnosis
Qualitative Component:
Inclusion Criteria:
- Participants from quantitative component
- Hospital staff, nurses, clinicians facilitative use of the service
- ≥18 years old
- Speak English or French
Exclusion Criteria:
• Hospital staff, nurses, clinicians who do not have experience with the service
No Contacts or Locations Provided
Responsible Party: | Soham Rej MD, MSc, Principal Investigator, Lady Davis Institute |
ClinicalTrials.gov Identifier: | NCT05450445 |
Other Study ID Numbers: |
2023-619 |
First Posted: | July 8, 2022 Key Record Dates |
Last Update Posted: | July 8, 2022 |
Last Verified: | July 2022 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Keywords provided by Soham Rej MD, MSc, Lady Davis Institute:
Older adults Hospital Inpatients Technology |